HIV RESEARCH CORE

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目及 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 夏威夷大学 CRC 项目已扩大到包括隶属于夏威夷大学约翰·A·伯恩斯医学院夏威夷艾滋病临床研究项目 (HACRP) 的艾滋病毒研究核心。 HACRP 位于 Leahi 医院，根据以下具体目标，强调艾滋病毒教育、研究和服务： 1) 发展临床研究能力，以评估 HIV-1 感染和艾滋病相关并发症的最佳治疗方法。 2) 为夏威夷所有 HIV-1 感染患者提供临床研究、试验和研究的机会。 3) 促进研究成果转化为临床护理，最终改善 HIV-1 感染患者的生活质量。 HACRP 还包括夏威夷艾滋病临床试验单位 (HACTU) 和 NeuroAIDS 专业神经科学研究计划 (NeuroAIDS SNRP)。 与 HACRP 的这种联系与 UH CRC 计划的具体目标一致，即建立和完善早期人类发育、生物营养、艾滋病毒和癌症方面的临床卓越和专业知识，特别强调与夏威夷州人口相关的临床问题。 此外，与 HACRP 共同开发的 HIV 研究核心提供了研究合作和伙伴关系的证据，这将进一步增强夏威夷大学竞争 NIH 机构临床转化科学奖 (CTSA) 的能力。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The UH CRC program has expanded to include a HIV Research Core in affiliation with the Hawaii AIDS Clinical Research Program (HACRP) of the UH John A. Burns School of Medicine. Located at Leahi Hospital, the HACRP emphasizes HIV education, research, and service in accordance with the following specific aims: 1) To develop clinical research capabilities to evaluate optimal therapies for HIV-1 infection and AIDS-associated complications. 2) To provide access to clinical research, trials, and studies for all HIV-1 infected patients in Hawaii. 3) To facilitate the transfer of research findings to clinical care which will ultimately improve the quality of life for patients with HIV-1 infection. THe HACRP also includes the Hawaii AIDS Clinical Trials Unit (HACTU) and the NeuroAIDS Specialized Neuroscience Research Program (NeuroAIDS SNRP). This affiliation with the HACRP is in congruence with the specific aims of the UH CRC program, namely, to build and refine clinical excellence and expertise in Early Human Development, Bionutrition, HIV and Cancer, with particular emphasis on issues of clinical relevance to the populations of the State of Hawaii. Moreover, the development of the HIV Research Core with the HACRP gives evidence of research collaboration and partnership which will further strengthen the University of Hawaii's ability to compete for a NIH institutional Clinical Translational Science Award (CTSA).